Oriola
0.915
EUR
-2.03 %
OKDBV
NASDAQ Helsinki
Medical Equipment & Services
Health Care
Oriola is a pharmaceutical group with a special focus on the distribution of pharmaceuticals to other companies in the industry. The company offers services to pharmacies and other pharmaceutical companies, which includes, for example, negotiations with suppliers and distribution of products. The largest presence is in the Nordic and Baltic countries. The head office is located in Espoo.
Analyst
Latest videos
Financial calendar
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Mariatorp Oy | 14.5 % | 13.4 % |
Wipunen varainhallinta oy | 5.0 % | 4.9 % |
Premium
This content is for our Premium customers only.
Insider Transactions
Insider | Date | Total value |
---|---|---|
Nina Mähönen | 06.11.2023 | 1,940EUR |
Mikael Nurmi | 03.11.2023 | 9,600EUR |
Premium
This content is for our Premium customers only.
Forum updates
Income statement
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
Revenue | 1,800.8 | 1,882.4 | 1,841.4 | 1,493.8 | 1,685.9 | 1,776.7 | 1,862.3 | 1,952.0 |
growth-% | 4.6 % | 4.5 % | -2.2 % | -18.9 % | 12.9 % | 5.4 % | 4.8 % | 4.8 % |
EBITDA | 63.1 | 65.4 | 68.6 | 30.1 | 27.7 | 26.7 | 28.1 | 30.2 |
EBIT (adj.) | 21.0 | 26.3 | 34.5 | 16.7 | 21.8 | 24.0 | 25.5 | 27.0 |
EBIT | 20.4 | 20.5 | 40.2 | -5.3 | 14.1 | 16.0 | 17.5 | 19.0 |
Profit before taxes | 14.3 | 14.7 | 35.4 | -17.6 | 1.2 | 10.5 | 16.5 | 18.6 |
Net income | 11.3 | 11.3 | 27.4 | -20.7 | -0.5 | 8.2 | 13.8 | 15.4 |
EPS (adj.) | 0.07 | 0.09 | 0.12 | 0.01 | 0.04 | 0.08 | 0.11 | 0.12 |
growth-% | -9.6 % | 44.4 % | 26.9 % | -94.1 % | 434.6 % | 112.5 % | 38.5 % | 8.2 % |
Dividend | 0.03 | 0.04 | 0.06 | 0.07 | 0.08 | 0.09 | 0.10 | 0.06 |
Dividend ratio | 48.2 % | 64.2 % | 39.7 % | -61.2 % | -3,085.9 % | 199.2 % | 131.9 % | 75.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
EBITDA-% | 3.5 % | 3.5 % | 3.7 % | 2.0 % | 1.6 % | 1.5 % | 1.5 % | 1.5 % |
EBIT-% (adj.) | 1.2 % | 1.4 % | 1.9 % | 1.1 % | 1.3 % | 1.4 % | 1.4 % | 1.4 % |
EBIT-% | 1.1 % | 1.1 % | 2.2 % | -0.4 % | 0.8 % | 0.9 % | 0.9 % | 1.0 % |
ROE | 6.9 % | 5.8 % | 12.4 % | -10.4 % | -0.3 % | 5.3 % | 9.1 % | 10.4 % |
ROI | 5.0 % | 4.6 % | 10.2 % | -3.1 % | 3.1 % | 6.7 % | 9.6 % | 10.6 % |
Login required
This content is only available for logged in users
Valuation
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
Share price (EUR) | 1.90 | 2.01 | 1.72 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 |
Shares | 181.3 | 181.3 | 181.3 | 181.3 | 181.3 | 181.3 | 181.3 | 181.3 |
Market cap | 344.5 | 364.5 | 311.9 | 166.8 | 165.9 | 165.9 | 165.9 | 165.9 |
Enterprise value | 471.6 | 465.3 | 288.2 | 103.5 | 86.3 | 82.3 | 89.8 | 100.6 |
EV/S | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 |
EV/EBITDA | 7.5 | 7.1 | 4.2 | 3.4 | 3.1 | 3.1 | 3.2 | 3.3 |
EV/EBIT (adj.) | 22.5 | 17.7 | 8.4 | 6.2 | 4.0 | 3.4 | 3.5 | 3.7 |
EV/EBIT | 23.1 | 22.7 | 7.2 | - | 6.1 | 5.1 | 5.1 | 5.3 |
P/E (adj.) | 29.1 | 21.3 | 14.4 | 131.3 | 24.4 | 11.5 | 8.3 | 7.7 |
P/E | 30.6 | 32.3 | 11.4 | - | - | 20.3 | 12.1 | 10.8 |
P/B | 2.0 | 1.7 | 1.4 | 1.0 | 1.0 | 1.1 | 1.1 | 1.1 |
P/S | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Dividend yield | 1.6 % | 2.0 % | 3.5 % | 7.6 % | 8.7 % | 9.8 % | 10.9 % | 7.0 % |
Equity ratio | 14.5 % | 19.8 % | 23.5 % | 18.3 % | 16.9 % | 15.8 % | 15.5 % | 14.6 % |
Gearing ratio | 74.9 % | 46.5 % | -10.5 % | -12.0 % | -21.8 % | -25.4 % | -20.8 % | -13.8 % |
Login required
This content is only available for logged in users
Quarter data
Q4/23 | 2023 | Q1/24 | Q2/24 | Q3/24 | Q4/24e | 2024e | Q1/25e | Q2/25e | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 386.5 | 1,493.8 | 375.1 | 439.5 | 424.4 | 446.9 | 1,685.9 | ||
EBITDA | 8.3 | 30.1 | 6.7 | 8.6 | 4.9 | 7.5 | 27.7 | ||
EBIT | 5.3 | -5.3 | 3.7 | 5.7 | 0.2 | 4.5 | 14.1 | ||
Profit before taxes | -0.8 | -17.6 | -2.0 | 2.8 | -2.2 | 2.5 | 1.2 | ||
Net income | -2.7 | -20.7 | -2.3 | 1.9 | -1.9 | 1.9 | -0.5 |
Login required
This content is only available for logged in users
Oriola-KD Oyj, Q3'24
Oriola Oyj: Oriola Corporation's Interim Report January-September 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits